Cadila Healthcare has reported results for first quarter ended June 30, 2020.
The company has reported 15- fold jump in its net profit of Rs 398.20 crore for the quarter under review as against net profit of Rs 26.40 crore for the same quarter in the previous year. Total income of the company increased 41.55% at Rs 1815.90 crore for Q1FY21 as compared Rs 1282.90 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 49.54% rise in its net profit at Rs 454.00 crore for the quarter under review as against net profit of Rs 303.60 crore for the same quarter in the previous year. Total income of the company increased by 4.08% at Rs 3662.40 crore for Q1FY21 as compared Rs 3518.90 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.55 |
Dr. Reddys Lab | 6217.15 |
Cipla | 1405.40 |
Zydus Lifesciences | 953.50 |
Lupin | 1589.10 |
View more.. |